Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03371940 · ClinicalTrials.gov registry record · NA
Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
A NA study of Depression and Type 2 Diabetes, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 3
- Study locations
NCT03371940: Completed NA study of Depression and Type 2 Diabetes, sponsored by Indiana University.
NCT03371940 is a NA study of Depression and Type 2 Diabetes that has completed, run by Indiana University. The registered enrollment target is 140 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03371940, a NA study of Depression and Type 2 Diabetes, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
Program ACTIVE II is a depression treatment study sponsored by the National Institutes of Health, Indiana University, Ohio University and West Virginia University. The purpose of this study is to test the effectiveness of two forms of treatment for depression for adults with type 2 diabetes: talk therapy (counseling) and exercise. Both of these forms of treatment have been proven to be effective in helping people with depression alone. In this study, the investigators will test to see if both of these approaches may be more effective in helping people live depression-free compared to talk therapy, exercise or usual care alone.
Primary Outcome
Based on our pilot data, mean glycemic control (as measured by HbA1c) is expected to improve .4% in participants in the EXER and CBT + EXER treatment conditions at POST (\~3 month) compared to baseline (de Groot et al., 2009).
Conditions Studied
Interventions
- BEHAVIORAL Program ACTIVE Exercise
- BEHAVIORAL Program ACTIVE CBT
- BEHAVIORAL Program ACTIVE
- BEHAVIORAL Usual Care - No intervention
Study Locations (3)
Indiana
- Indiana University - Indianapolis
Ohio
- Ohio University - Athens
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2012-01-01 |
| Est. Completion | 2017-07-31 |
| Phase | NA |
What the finished NCT03371940 record still lists
NCT03371940 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Program ACTIVE Exercise is the first listed.
NCT03371940 reports a single indexed study location in Indiana, Ohio, West Virginia.
Frequently Asked Questions
What is clinical trial NCT03371940 about?
NCT03371940 is a clinical study titled "Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes". Program ACTIVE II is a depression treatment study sponsored by the National Institutes of Health, Indiana University, Ohio University and West Virginia University. The purpose of this study is to test the effectiveness of two forms of treatment for depression for adults with type 2 diabetes: talk th...
What is the current status of trial NCT03371940?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2012-01-01. Estimated completion is 2017-07-31.
What conditions does trial NCT03371940 study?
This clinical trial studies the following conditions: Depression, Type 2 Diabetes.
What interventions are being tested in trial NCT03371940?
The interventions under investigation include: Program ACTIVE Exercise (BEHAVIORAL), Program ACTIVE CBT (BEHAVIORAL), Program ACTIVE (BEHAVIORAL), Usual Care - No intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03371940?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03371940 being conducted?
This trial has 3 study locations across Indiana, Ohio, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03371940's enrollment target sits among peer trials
140 272nd of 679 higher than 406 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy